nSMOL Improves the Speed and Accuracy of mAb Bioanalysis

As scientists gain an advanced understanding of diseases at the molecular level, the biopharmaceutical industry is significantly increasing research, production and manufacturing of monoclonal antibodies (mAbs). In fact, five of the top-ten best-selling drugs in the U.S. in 2016 were mAbs.